Biological activities of C3βc, a novel neutrophil chemoattractant derived from the β-chain of rat complement C3

被引:4
|
作者
Nakagawa, H [1 ]
Sunada, Y [1 ]
Ando, Y [1 ]
机构
[1] Toyama Med & Pharmaceut Univ, Fac Pharmaceut Sci, Dept Physiol Chem, Toyama 9300194, Japan
关键词
D O I
10.1046/j.1365-2567.1998.00506.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Biological activities of C3 beta c, which is a C-tenminal fragment of the beta-chain of rat complement C3, have been studied by in vivo and in vitro experiments. C3 beta c was purified as a novel neutrophil chemoattractant from the exudate of the chronic phase of rat carrageenin-induced inflammation. The purified C3 beta c induced neutrophil chemotaxis in vivo when C3 beta c was injected into the preformed air-pouch on the back of rats. C3 beta c transiently increased the intracellular free Ca2+ concentration of neutrophils, and enhanced the adhesion of neutrophils to fibrinogen in vitro, suggesting that C3 beta c has the ability to express an adhesion molecule of rat neutrophils. In addition, C3 beta c at low concentrations (10(-10)-10(-11) M) stimulated rat macrophages to produce cytokine-induced neutrophil chemoattractant-2, a member of the interleukin-8 family. Furthermore, C3 beta c enhanced vascular permeability in vivo, which is suppressed by cyproheptadine, suggesting that C3 beta c may have the characteristics of an anaphylatoxin. Our results suggest that C3 beta c contributes to oedema formation and neutrophil accumulation at inflammatory sites in rats.
引用
收藏
页码:253 / 257
页数:5
相关论文
共 50 条
  • [1] Development of a complement C3 humanized rat as a new model for evaluating novel C3 inhibitors
    Lin, Feng
    Zhang, Lingjun
    Yang, Maojing
    Hughes, Elizabeth
    Saunders, Thomas
    Chen, Jin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [2] INHERITED COMPLEMENT C3 DEFICIENCY - A DEFECT IN C3 SECRETION
    KATZ, Y
    SINGER, L
    WETSEL, RA
    SCHLESINGER, M
    FISHELSON, Z
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (07) : 1517 - 1522
  • [3] Complement C3 and macrosomia
    Haddouche, M.
    Aribi, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 76 - 76
  • [4] C3 or not C3 - That is the question
    Watts, SW
    HYPERTENSION, 2004, 44 (01) : 25 - 26
  • [5] Development of a C3 humanized rat as a new model for evaluating novel C3 inhibitors
    Chen, Jin
    Zhang, Lingjun
    Yang, Maojing
    Hughes, Elizabeth
    Saunders, Thomas
    Lin, Feng
    IMMUNOBIOLOGY, 2023, 228 (05) : 1 - 2
  • [6] Development of a C3 Humanized Rat as a New Model for Evaluating Novel C3 Inhibitors
    Chen, Jin Y.
    Zhang, Lingjun
    Yang, Maojing
    Hughes, Elizabeth D.
    Freeman, Zachary T.
    Saunders, Thomas L.
    Lin, Feng
    JOURNAL OF INNATE IMMUNITY, 2024, 16 (01) : 56 - 65
  • [7] TRENDING C3 IN C3 GLOMERULOPATHY
    Nester, Carla
    Breheny, Patrick
    Keleher, Monica
    Martin, Bertha
    Zhang, Yuzhou
    Smith, Richard
    MOLECULAR IMMUNOLOGY, 2019, 114 : 484 - 484
  • [8] Characterization of C3 in C3 glomerulopathy
    Sethi, Sanjeev
    Vrana, Julie A.
    Fervenza, Fernando C.
    Theis, Jason D.
    Sethi, Amit
    Kurtin, Paul J.
    Zhang, Yuzhou
    Smith, Richard J. H.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (03) : 459 - 465
  • [9] Extrahepatic secreted complement C3 contributes to circulating C3 levels in humans
    Naughton, MA
    Botto, M
    Carter, MJ
    Alexander, GJM
    Goldman, JM
    Walport, MJ
    JOURNAL OF IMMUNOLOGY, 1996, 156 (08): : 3051 - 3056
  • [10] A NEUTROPHIL CHEMOTACTIC FACTOR FROM COMPLEMENT C3 PRODUCED BY A TISSUE PROTEASE
    HILL, JH
    WARD, PA
    FEDERATION PROCEEDINGS, 1969, 28 (02) : 485 - &